Panasonic Set for R...
Health Care: Drugs
Nektar Therapeutics Inc. (NKTR: NASDAQ)
$7.17 0.25 | 3.61%
02/03/12 - 04:00 PM ET
2.06M / 1.33M
Vol / Avg. Vol:7.01 / 6.92
Open / Prev. Close:6.99 - 7.26
Today's Range:4.07 - 11.34
52 Wk Range:28.15%
Performance YTD:TheStreet Rating:
Portfolios with NKTR
- Portfolio NameUser Type
- Contributor10 Health Care Stocks With ...
- Contributor10 Mid-Caps With Upside
- Contributor10 Pharma Stocks With Upside
- ProDriehaus Capital
- UserSUPRATRADE 7 Top Stocks for...
- UserSUPRATRADE 10 Stock Picks F...
- UserASCO 2010
- UserPART 3 JPMorgan 28th Annual...
- UserBVF Inc.
- UserPANTERA GROUP 215
Latest NKTR Headlines from TheStreet
- Nektar Stock Hits New 52-Week Low (NKTR) 11.16.11 | 12:11 pm
- Nektar Bulls Fight Through Pain 10.04.11 | 08:10 am
- Nektar Stock Hits New 52-Week Low (NKTR) 10.03.11 | 10:10 am
- Nektar Stock Hits New 52-Week Low (NKTR) 08.03.11 | 10:08 am
- Nektar Stock Hits New 52-Week Low (NKTR) 07.26.11 | 10:07 am
- Nektar Stock Hits New 52-Week Low (NKTR) 06.24.11 | 02:06 pm
- Stocks Under $5: Stealth Stock on Sale
06.16.11 | 06:06 am - Nektar Stock Hits New 52-Week Low (NKTR) 06.14.11 | 03:06 pm
- Nektar Stock Hits New 52-Week Low (NKTR) 06.06.11 | 03:06 pm
- ASCO Conference Blog Recap 06.04.11 | 05:06 pm
Press Releases for NKTR
- Baxter Initiates Phase I Clinical Trial Of Longer-acting Recombinant FVIII Treatment For Hemophilia A - PR Newswire 01.05.12 | 09:01 am
- Nektar Therapeutics' President And CEO, Howard W. Robin, To Present At The 30th Annual J.P. Morgan Healthcare Conference In San Francisco, CA - PR Newswire 01.04.12 | 06:01 pm
- Nektar Announces Positive Clinical Data From Second Phase 1 Clinical Study Of NKTR-181, A Novel Opioid Analgesic Molecule To Treat Chronic Pain - PR Newswire 12.13.11 | 07:12 am
- Nektar Therapeutics' President And CEO, Howard W. Robin, To Present At The UBS 2011 Global Life Sciences Conference In New York City - PR Newswire 09.14.11 | 08:09 pm
- Nektar Therapeutics' President And CEO Howard W. Robin To Present At The 31st Annual Cowen And Company Healthcare Conference In Boston - PR Newswire 03.01.11 | 09:03 am
- Nektar Therapeutics Completes Public Offering Of Common Stock - PR Newswire 01.24.11 | 04:01 pm
- Nektar Therapeutics Prices Public Offering Of Common Stock - PR Newswire 01.19.11 | 09:01 am
- Nektar Therapeutics' President And CEO, Howard W. Robin, To Present At The 29th Annual J.P. Morgan Healthcare Conference In San Francisco, CA - PR Newswire 01.05.11 | 08:01 am
- Nektar To Announce Financial Results For The Second Quarter Of 2010 On Wednesday, July 28, 2010, After Close Of U.S.-Based Financial Markets - PR Newswire 07.21.10 | 09:07 am
- Jennerex Appoints Dr. Hoyoung Huh To Its Board Of Directors - PR Newswire 01.11.10 | 09:01 am
Partner Headlines for NKTR
- Nektar Therapeutics Presents Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer - Benzinga 09.10.11 | 04:09 pm
- 10 Stocks With Bullish Momentum Backed By Strong Top Line Growth - Seeking Alpha 08.24.11 | 08:08 am
- 14 Oversold Stocks Trading Near Lows but Being Bought Up by the Smart Money - Seeking Alpha 07.12.11 | 09:07 am
- Are These 10 Sick Healthcare Companies Terminally Ill? - Seeking Alpha 07.07.11 | 09:07 am
- Arthur Cohen and Joseph Healey's Successful Stock Picks - Seeking Alpha 05.23.11 | 08:05 am
- Company News for May 18, 2011 - Corporate Summary - Zacks 05.18.11 | 10:05 am
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- AZN's Opioid Drug Progresses - Analyst Blog - Zacks 03.25.11 | 06:03 pm
- Company News for January 20, 2011 - Corporate Summary - Zacks 01.20.11 | 10:01 am
- BROOKFIELD ASST (BAM) - Profit Tracks - Zacks 01.13.11 | 01:01 am
